Labeling of biotech salmon draws opposing views during public hearing

09/22/2010 | Wall Street Journal, The

During a public hearing conducted by the FDA on Tuesday, several consumer groups called on the agency to require AquaBounty Technology's biotech salmon, AquAdvantage, to carry a label indicating that it is genetically engineered. Meanwhile, AquaBounty and other industry representatives said the agency should comply with the current policies on labeling.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX